Endonovo Therapeutics, Inc. (ENDV)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
Jul 31, 2025, 1:07 PM EDT
Endonovo Therapeutics Market Cap
Endonovo Therapeutics has a market cap or net worth of $241.32 thousand as of August 1, 2025. Its market cap has decreased by -72.37% in one year.
Market Cap
241.32K
Enterprise Value
n/a
Revenue
255.72K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 20, 2013, Endonovo Therapeutics's market cap has increased from 78.90K to 241.32K, an increase of 205.86%. That is a compound annual growth rate of 9.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 241.32K | 10.93% |
| Dec 31, 2024 | 217.55K | -92.16% |
| Dec 29, 2023 | 2.77M | -20.72% |
| Dec 30, 2022 | 3.50M | 211.37% |
| Dec 31, 2021 | 1.12M | 127.79% |
| Dec 31, 2020 | 493.17K | -74.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| American Oncology Network | 408.39M |
| Glass House Brands | 396.28M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |